REGULATORY INTELLIGENCE·Recall
FDA Class II Recall: Par Sterile Products' Vasostrict Superpotency Poses Supply Chain Risk
Par Sterile Products LLC has initiated a nationwide Class II recall for Vasostrict (vasopressin) injection due to superpotency. This event, impacting 1,721 cartons, signals critical quality control failures in manufacturing stability testing. Procurement and supply chain leaders must assess immediate inventory, potential shortages, and the broader implications for injectable drug sourcing and patient safety.
90-Day Activity